Central Pharmaceuticals Ltd. (DSE: CENTRALPHL)

Central Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 18, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Market Capitalization	1,042	1,486	1,569	1,581	1,593	1,509
Market Cap Growth	203.96%	-5.34%	-0.76%	-0.75%	5.56%	-12.96%
Enterprise Value	1,328	1,752	1,818	1,803	1,818	1,708
Last Close Price	8.70	12.40	13.10	13.20	13.30	12.45
PE Ratio	-	-	-	-	-	26.44
PS Ratio	9.54	50.65	60.37	10.67	11.37	4.91
PB Ratio	1.23	2.22	2.20	2.02	2.02	0.85
P/TBV Ratio	4.33	2.22	2.20	2.02	2.02	0.85
P/OCF Ratio	-	-	-	880.40	-	146.18
EV/Sales Ratio	11.88	59.75	69.92	12.17	12.97	5.55
EV/EBITDA Ratio	-	-	-	45.42	-	12.30
EV/EBIT Ratio	-	-	-	264.59	-	17.29
Debt / Equity Ratio	0.34	0.40	0.38	0.32	0.29	0.12
Debt / EBITDA Ratio	-	-	-	6.33	-	1.48
Asset Turnover	-	0.02	0.02	0.11	0.07	0.13
Inventory Turnover	-	1.90	1.26	2.06	1.95	0.29
Quick Ratio	0.34	0.25	0.25	0.26	0.20	1.13
Current Ratio	1.18	1.18	1.25	1.37	1.31	2.76
Return on Equity (ROE)	-	-6.35%	-9.12%	-1.08%	-86.06%	3.19%
Return on Assets (ROA)	-	-2.32%	-2.49%	0.31%	-35.91%	2.55%
Return on Capital (ROIC)	-	-3.11%	-3.31%	0.42%	-45.76%	3.09%
Earnings Yield	-5.55%	-2.96%	-4.35%	-0.54%	-69.48%	3.78%
FCF Yield	-0.00%	-0.02%	-0.07%	-0.30%	-0.03%	-0.06%
Dividend Yield	0.00%	-	-	-	-	0.80%
Buyback Yield / Dilution	-2.36%	-	-	-	-	-
Total Shareholder Return	-2.36%	-	-	-	-	0.80%

Source: S&P Capital IQ. Standard template. Financial Sources.